Thomson Reuters(Reuters) - Valeant Pharmaceuticals International Inc on Monday said a group of company executives will immediately take over for its chief executive officer until he returns from medical leave, sending shares tumbling 10 percent. The Canadian company said CEO Michael Pearson, 56, was being treated for severe pneumonia.